Enxnet 10-Q 14 Feb 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Dec. 31, 2013	Jan. 29, 2014
Document and Entity Information:	'	'
Entity Registrant Name	'EnXnet Inc	'
Document Type	'10-Q	'
Document Period End Date	31-Dec-13	'
Amendment Flag	'false	'
Entity Central Index Key	'0001083706	'
Current Fiscal Year End Date	'--03-31	'
Entity Common Stock, Shares Outstanding	'	49,451,518
Entity Filer Category	'Smaller Reporting Company	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Well-known Seasoned Issuer	'No	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Balance_Sheets_Unaudited

Balance Sheets (Unaudited) (USD $)	Dec. 31, 2013		Mar. 31, 2013
CURRENT ASSETS	'		'
Cash	$32,417		$8,098
Prepaid expenses	802		1,027
TOTAL CURRENT ASSETS	33,219		9,125
OTHER ASSETS	'		'
Patent technology, net	36,224		37,778
Deposits	1,137		1,137
TOTAL OTHER ASSETS	37,361		38,915
TOTAL ASSETS	70,580		48,040
CURRENT LIABILITIES	'		'
Accounts payable and accrued expenses	546,434		524,556
Advances from officer - related party	12,500		10,500
Advances from stockholder	32,400		32,400
Convertible notes payable - stockholders	200,000		180,000
Convertible notes payable - related parties	829,118		809,118
TOTAL CURRENT LIABILITIES	1,620,452		1,556,574
STOCKHOLDERS DEFICIT	'		'
Common stock	2,473	[1]	2,399	[1]
Additional paid-in capital	5,564,851		5,468,153
Accumulated deficit	-7,017,196		-6,879,086
Other comprehensive income	-100,000		-100,000
TOTAL STOCKHOLDERS EQUITY (DEFICIT)	-1,549,872		-1,508,534
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	$70,580		$48,040
[1]	Common stock, $0.00005 par value; 200,000,000 shares authorized, 49,451,518 and 47,981,518 shares issued and outstanding

Balance_Sheets_Parenthetical_U

Balance Sheets - Parenthetical (Unaudited) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Statement of Financial Position	'	'
Common Stock Par Value	$0.00	$0.00
Common Stock Authorized	200,000,000	200,000,000
Common Stock Issued	49,451,518	49,451,518
Common Stock Outstanding	47,981,518	47,981,518

Statements_of_Operations_Unaud

Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
EXPENSES	'	'	'	'
Consulting fees	$15,222	$1,000	$25,859	$34,667
Depreciation & amortization	518	518	1,554	1,554
Payroll	13,290	52,374	37,138	144,680
Professional services	15,895	704	37,219	21,856
Occupancy	3,778	3,417	9,854	10,165
Office	1,037	770	3,408	4,445
Travel	2,142	288	2,791	3,922
Other	447	485	1,697	1,863
Total Expenses	52,329	59,556	119,520	223,152
LOSS FROM OPERATIONS	-52,329	-59,556	-119,520	-223,152
OTHER INCOME (EXPENSE)	'	'	'	'
Interest expense	-6,250	-6,204	-18,590	-18,431
NET LOSS	($58,579)	($65,760)	($138,110)	($241,583)
BASIC AND DILUTED NET LOSS PER SHARE	$0	$0	$0	$0
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	49,191,192	47,569,018	48,977,919	46,781,309

Statements_of_Cash_Flows_Unaud

Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES	'	'
Net Income (loss)	($138,110)	($241,583)
Adjustments to reconcile net loss to net cash provided by (used in) operations:	'	'
Depreciation and amortization	1,554	1,554
Common stock issued for services	5,000	101,000
Stock options expense	23,272	19,080
Changes in operating assets and liabilities:	'	'
Decrease (increase) in prepaid expenses	225	528
Increase (decrease) in accounts payable & accrued expenses	21,878	11,230
Net cash used in operating activities	-86,181	-108,191
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from stock sales	68,500	100,000
Proceeds from note payable	40,000	'
Proceeds from advances from officer and stockholders	3,000	18,900
Repayment of advances from officer and stockholders	-1,000	-11,000
Net cash provided by (used in) financing activities	110,500	107,900
NET INCREASE (DECREASE) IN CASH	24,319	-291
CASH - Beginning of period	8,098	11,966
CASH - End of period	32,417	11,675
NON-CASH FINANCING AND INVESTING TRANSACTIONS:	'	'
Conversion of account payable - related parties to note payable - related parties	'	$36,900

Note_1_Basis_of_Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Dec. 31, 2013
Notes	'
Note 1 - Basis of Presentation	'
	NOTE 1 - BASIS OF PRESENTATION
	The accompanying unaudited financial statements of EnXnet, Inc. (“EnXnet” or “the Company”) for the nine months ended December 31, 2013 have been prepared in accordance with generally accepted accounting principles in the United States of America, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission for interim financial information. Accordingly, the financial statements do not include all information and footnotes required by generally accepted accounting principles in the United States for complete annual financial statements. In the opinion of management, the accompanying unaudited condensed interim financial statements reflect all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation. The accompanying financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s March 31, 2013 Annual Report on Form 10-K.

Note_2_Going_Concern

Note 2 - Going Concern	9 Months Ended
	Dec. 31, 2013
Notes	'
Note 2 - Going Concern	'
	NOTE 2 – GOING CONCERN
	The Company has a working capital deficit and has incurred losses since inception. These factors raise substantial doubt about the Company’s ability to continue as a going concern.  The financial statements do not include any adjustments that may be necessary if the Company is unable to continue as a going concern.
	Management of the Company has undertaken certain actions to address these conditions.    Funds required to carry out management’s plans are expected to be derived from future stock sales and borrowings from outside parties. There can be no assurances that the Company will be successful in executing its plans.

Note_3_Convertible_Notes_Payab

Note 3 - Convertible Notes Payable	9 Months Ended
	Dec. 31, 2013
Notes	'
Note 3 - Convertible Notes Payable	'
	NOTE 3 – CONVERTIBLE NOTES PAYABLE
	Convertible notes payable-related parties consists of the following:
			31-Dec-13		31-Mar-13
	3% convertible note payable to Ryan Corley, President of the Company, due on demand		21,705		21,705
	2% convertible notes payable to Ryan Corley, due on demand		640,750		620,750
	2% convertible note payable to an entity controlled by Ryan Corley,  due on demand		48,900		48,900
	3% convertible notes payable to an entity controlled by Ryan Corley, due on demand		111,350		111,350
	3% convertible notes payable to Douglas Goodsell, due on demand		6,413		6,413
	Total notes payable-related party	$	829,118	$	809,118
	Convertible notes payable consist of the following:
			31-Dec-13		31-Mar-13
	4% convertible notes payable to a stockholder, due on demand, convertible into a maximum of 350,000 common shares		175,000		175,000
	2% convertible notes payable to stockholders, due on demand, convertible into a maximum of 600,000 common shares		25,000		5,000
	Total notes payable	$	200,000	$	180,000

Note_4_Advances_From_and_Notes

Note 4 - Advances From and Notes Payable To Officer	9 Months Ended
	Dec. 31, 2013
Notes	'
Note 4 - Advances From and Notes Payable To Officer	'
	NOTE 4 – ADVANCES FROM AND NOTES PAYABLE TO OFFICER
	Advances from a stockholder at both December 31, 2013 and March 31, 2013 were $32,400.
	Our CEO, Ryan Corley, has made advances to the Company in prior years. During the nine months ended December 31, 2013, the CEO made additional unsecured advances totaling $3,000. During nine months ended December 31, 2013 the Company made payments on these advances of $1,000.
	The Company has notes payable to the CEO totaling $662,455 and $642,455 as of December 31, 2013 and March 31, 2013. Accrued interest owed on these notes is $145,437 and $135,569. These notes and accrued interest are convertible into 15,593,325 and 14,880,388 shares, respectively.
	An entity controlled by the CEO has made unsecured advances and notes payables to the Company. Advances and notes payable from the entity controlled by the CEO as of December 31, 2013 and March 31, 2013 is $160,250. Accrued interest owed on these notes was $19,829 and $16,575, respectively. These notes and accrued interest are convertible into 2,902,681 and 2,851,340 shares, respectively.

Note_5_Common_Stock_Transactio

Note 5 - Common Stock Transactions	9 Months Ended
	Dec. 31, 2013
Notes	'
Note 5 - Common Stock Transactions	'
	NOTE 5 - COMMON STOCK TRANSACTIONS
	The Company sold 1,370,000 shares for $68,500 in cash during the nine months ended December 31, 2013.
	The Company issued 100,000 shares for services valued at $5,000 during the nine months ended December 31, 2013.

Note_6_Stock_Options

Note 6 - Stock Options	9 Months Ended
	Dec. 31, 2013
Notes	'
Note 6 - Stock Options	'
	NOTE 6 – STOCK OPTIONS
	On July 24, 2001, the Company filed with the SEC Form S-8, for its 2002 Stock Option Plan, (the Plan). An aggregate amount of common stock that may be awarded and purchased under the Plan is 3,000,000 shares of the Company’s common stock. Under the Plan during the years ended March 31, 2013, the Company granted stock options to employees and members of the Board of Directors in the amount of 2,190,000. The Company recognized option expense of $5,548 due to the vesting of these options for the nine months ended December 31, 2013.
	On July 2, 2013, the Company amended the terms of the outstanding stock options to extend the expiry dates.  The Company recognized $10,744 of additional expense associated with the amended options.
	On November 25, 2013, the Company granted 500,000 stock options to a consultant.  The Company recognized option expense of $6,980
	A summary of the status of the Company’s stock options as of December 31, 2013 is presented below:
		31-Dec-13
	Options outstanding at beginning of year	3,290,000
	Options granted	500,000
	Options exercised	-
	Options canceled	-
	Options outstanding at end of year	3,790,000
	The following table summarizes the information about the stock options as of December 31, 2013:
		Range of	Number	Weighted Average	Weighted Average	Number	Weighted Average
		Exercise Price	Outstanding	Remaining	Exercise Price	Exercisable	Exercise Price
				Contractual Life	(Total shares)		(Exercisable
				Years			shares)
		$0.12	1,990,000	3.8	$0.12	1,990,000	$0.12
		.10-.15	800,000	0.47	0.12	800,000	0.12
		0.25	200,000	1.75	0.25	-	-
		0.5	300,000	2.75	0.5	100,000	0.5
		0.15	500,000	2.9	0.15	500,000	0.15
		$ .10 – .50	3,790,000	2.57	$0.16	3,390,000	$0.14

Note_3_Convertible_Notes_Payab1

Note 3 - Convertible Notes Payable: Schedule of Convertible Notes Payable - Related Parties (Tables)	9 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Convertible Notes Payable - Related Parties	'
	Convertible notes payable-related parties consists of the following:
			31-Dec-13		31-Mar-13
	3% convertible note payable to Ryan Corley, President of the Company, due on demand		21,705		21,705
	2% convertible notes payable to Ryan Corley, due on demand		640,750		620,750
	2% convertible note payable to an entity controlled by Ryan Corley,  due on demand		48,900		48,900
	3% convertible notes payable to an entity controlled by Ryan Corley, due on demand		111,350		111,350
	3% convertible notes payable to Douglas Goodsell, due on demand		6,413		6,413
	Total notes payable-related party	$	829,118	$	809,118

Note_3_Convertible_Notes_Payab2

Note 3 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Tables)	9 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Convertible Notes Payable	'
	Convertible notes payable consist of the following:
			31-Dec-13		31-Mar-13
	4% convertible notes payable to a stockholder, due on demand, convertible into a maximum of 350,000 common shares		175,000		175,000
	2% convertible notes payable to stockholders, due on demand, convertible into a maximum of 600,000 common shares		25,000		5,000
	Total notes payable	$	200,000	$	180,000

Note_6_Stock_Options_Schedule_

Note 6 - Stock Options: Schedule of Share-based Compensation, Stock Options, Activity (Tables)	9 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Compensation, Stock Options, Activity	'
		31-Dec-13
	Options outstanding at beginning of year	3,290,000
	Options granted	500,000
	Options exercised	-
	Options canceled	-
	Options outstanding at end of year	3,790,000

Note_6_Stock_Options_Schedule_1

Note 6 - Stock Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Tables)	9 Months Ended
	Dec. 31, 2013
Tables/Schedules	'
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range	'
		Range of	Number	Weighted Average	Weighted Average	Number	Weighted Average
		Exercise Price	Outstanding	Remaining	Exercise Price	Exercisable	Exercise Price
				Contractual Life	(Total shares)		(Exercisable
				Years			shares)
		$0.12	1,990,000	3.8	$0.12	1,990,000	$0.12
		.10-.15	800,000	0.47	0.12	800,000	0.12
		0.25	200,000	1.75	0.25	-	-
		0.5	300,000	2.75	0.5	100,000	0.5
		0.15	500,000	2.9	0.15	500,000	0.15
		$ .10 – .50	3,790,000	2.57	$0.16	3,390,000	$0.14

Note_3_Convertible_Notes_Payab3

Note 3 - Convertible Notes Payable: Schedule of Convertible Notes Payable - Related Parties (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Notes Payable, Related Parties	$829,118	$809,118
3% convertible note payable to Ryan Corley, President of the Company, due on demand	'	'
Notes Payable, Related Parties	21,705	21,705
2% convertible notes payable to Ryan Corley, due on demand	'	'
Notes Payable, Related Parties	640,750	620,750
2% convertible note payable to an entity controlled by Ryan Corley, due on demand	'	'
Notes Payable, Related Parties	48,900	48,900
3% convertible notes payable to an entity controlled by Ryan Corley, due on demand	'	'
Notes Payable, Related Parties	111,350	111,350
3% convertible notes payable to Douglas Goodsell, due on demand	'	'
Notes Payable, Related Parties	$6,413	$6,413

Note_3_Convertible_Notes_Payab4

Note 3 - Convertible Notes Payable: Schedule of Convertible Notes Payable (Details) (USD $)	Dec. 31, 2013	Mar. 31, 2013
Notes Payable	$200,000	$180,000
4% convertible notes payable to a stockholder, due on demand, convertible into a maximum of 350,000 common shares	'	'
Notes Payable	175,000	175,000
2% convertible notes payable to stockholders, due on demand, convertible into a maximum of 600,000 common shares	'	'
Notes Payable	$25,000	$5,000

Note_4_Advances_From_and_Notes1

Note 4 - Advances From and Notes Payable To Officer (Details) (USD $)	9 Months Ended			0 Months Ended		9 Months Ended		0 Months Ended	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2013	Mar. 31, 2013	Mar. 31, 2013	Dec. 31, 2013
				A stockholder	A stockholder	Chief Executive Officer	Chief Executive Officer	An entity controlled by the CEO	An entity controlled by the CEO
Proceeds from Related Party Debt	'	'	'	$32,400	$32,400	$3,000	'	$160,250	$160,250
Repayment of advances from officer and stockholders	1,000	11,000	'	'	'	1,000	'	'	'
Convertible notes payable - related parties	829,118	'	809,118	'	'	662,455	642,455	'	'
Interest Payable, Current	'	'	'	'	'	$145,437	$135,569	$16,575	$19,829
Number of shares convertible from notes	'	'	'	'	'	15,593,325	'	'	2,902,681
Number of shares convertible from accrued interest	'	'	'	'	'	14,880,388	'	'	2,851,340

Note_5_Common_Stock_Transactio1

Note 5 - Common Stock Transactions (Details) (USD $)	9 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Details	'	'
Stock Issued During Period, Shares, Other	1,370,000	'
Stock Issued During Period, Value, Other	$68,500	'
Common stock issued for services	100,000	'
Common stock issued for services	$5,000	$101,000

Note_6_Stock_Options_Details

Note 6 - Stock Options (Details) (USD $)	12 Months Ended		9 Months Ended				9 Months Ended
	Dec. 31, 2013	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Jul. 24, 2001	Dec. 31, 2013
			Years ended March 31, 2013	25-Nov-13	2002 Stock Option Plan	2002 Stock Option Plan	2002 Stock Option Plan, Amended
							2-Jul-13
Common Stock Authorized	200,000,000	200,000,000	'	'	'	3,000,000	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures	'	'	2,190,000	'	'	'	'
Stock or Unit Option Plan Expense	'	'	'	$6,980	$5,548	'	$10,744
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	500,000	'	'	500,000	'	'	'

Note_6_Stock_Options_Schedule_2

Note 6 - Stock Options: Schedule of Share-based Compensation, Stock Options, Activity (Details)	12 Months Ended
	Dec. 31, 2013
Details	'
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Beginning Balance	3,290,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number, Ending Balance	3,790,000

Note_6_Stock_Options_Schedule_3

Note 6 - Stock Options: Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range (Details) (USD $)	9 Months Ended
	Dec. 31, 2013
$0.12	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	1,990,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'3 years 9 months 18 days
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$0.12
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	1,990,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0.12
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$0.12
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.12
.10-.15	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	800,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'5 months 19 days
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$0.12
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	800,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0.12
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$0.15
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.10
0.25	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	200,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'1 year 9 months
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$0.25
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$0.25
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.25
0.5	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	300,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'2 years 9 months
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$0.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	100,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$0.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.50
0.15	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	500,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'2 years 10 months 24 days
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$0.15
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	500,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0.15
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$0.15
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.15
$ .10 - .50	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Outstanding Options	3,790,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term	'2 years 6 months 25 days
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price	$0.16
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Number of Exercisable Options	3,390,000
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Exercisable Options, Weighted Average Exercise Price	$0.14
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit	$0.50
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit	$0.10